
LeadersLink Program

Foundations’ Role in Supporting Clinical Trial Innovation Toolkit

FasterCures Quarterly Update: July 2023

Cell and Gene Therapies: Looking Ahead to 2022

Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment

The Drive for More Diverse and Representative Clinical Trials

Master Protocols, Adaptive Designs, and Bayesian Statistics – Oh My

Opportunities for Patient Group Engagement in Clinical Trials

Technology Enabling Decentralized Trials, Novel Endpoints, Real World Data

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
